Zobrazeno 1 - 5
of 5
pro vyhledávání: '"L. A. Khublarova"'
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4, Pp 111-114 (2018)
Tardive drug dystonia / dyskinesia is one of the rare, and at the same time, the most severe motor complications associated with the use of pharmacological drugs. Complex assessment of risk factors for the development of tardive drug-induced side eff
Externí odkaz:
https://doaj.org/article/02e10ff93ae64d17a1feacf2c61fa618
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 3, Pp 46-50 (2018)
Clinical heterogeneity of tremor in Parkinson’s disease suggests a differentiated approach in choosing a correction therapy for motor defects. The article focuses on a variety of patterns of antiparkinsonian drug administration depending on the typ
Externí odkaz:
https://doaj.org/article/fbe9a530475f466e8a53729a12a62446
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 3, Pp 336-344 (2016)
Background: Essential tremor is one of the most prevalent extrapyramidal disorders, while treatment efficacy in such patients remains low. Clinical polymorphism of essential tremor requires a differentiated treatment approach, that should be implemen
Externí odkaz:
https://doaj.org/article/b79514c51a0b43728b180cdf50b12455
Autor:
T. S. Usenko, K. A. Senkevich, A. I. Bezrukova, G. V. Baydakova, K. S. Basharova, A. S. Zhuravlev, E. V. Gracheva, A. V. Kudrevatykh, I. V. Miliukhina, I. V. Krasakov, L. A. Khublarova, I. V. Fursova, D. V. Zakharov, A. A. Timofeeva, Y. A. Irishina, E. I. Palchikova, N. M. Zalutskaya, A. K. Emelyanov, E. Y. Zakharova, S. N. Pchelina
Publikováno v:
Molecular Neurobiology. 59:2277-2287
Autor:
T S, Usenko, K A, Senkevich, A I, Bezrukova, G V, Baydakova, K S, Basharova, A S, Zhuravlev, E V, Gracheva, A V, Kudrevatykh, I V, Miliukhina, I V, Krasakov, L A, Khublarova, I V, Fursova, D V, Zakharov, A A, Timofeeva, Y A, Irishina, E I, Palchikova, N M, Zalutskaya, A K, Emelyanov, E Y, Zakharova, S N, Pchelina
Publikováno v:
Molecular neurobiology. 59(4)
The synucleinopathies are a group of neurodegenerative diseases characterized by the oligomerization of alpha-synuclein protein in neurons or glial cells. Recent studies provide data that ceramide metabolism impairment may play a role in the pathogen